| Publication Date | Title | Author(s) |
| Apr-2020 | COVID-19 rapid evidence profile # 2: What is known about the spread and management of COVID-19 in non-health workplaces? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #10: What screening approaches can be used in non-healthcare settings (e.g., universities, stores and office settings) to identify people who may have COVID-19 and need to take appropriate action? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #11: What is the evidence related to playground equipment and risk of COVID-19 transmission? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Sharma, K; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #12: What insights from the available evidence and jurisdictional scans can inform who should be tested for COVID-19 and how frequently, where, by whom and with what follow-up actions should they be tested? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #13: What pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them, respectively? | Waddell, K; Wilson, MG; Bullock, HL; Evans, C; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #14: Where and with what impacts have shifts from in-person to virtual approaches occurred in the delivery of healthcare services in general and mental health and addictions services in particular? | Waddell, K; Bullock, HL; Evans, C; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Mansilla, C; Wang, Q; Bhuiya, AR; Ahmad, A; Filbey, L; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #15: What frameworks from available evidence and experiences in other countries can inform what needs to be done to plan for future waves of COVID-19? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Bhuiya, AR; Voorheis, P; Ahmad, A; Gao, C; Alam, S; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #16: What provider-led virtual-care services can be used to replace in-person care in hospital-based ambulatory care settings? | Wilson, MG; Waddell, K; Wang, Q; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Ahmad, A; Alam, S; Bhuiya, AR; Lavis, JN |
| Jan-2022 | COVID-19 rapid evidence profile #27: What measures and approaches can protect the most vulnerable in hospitals when outbreaks of Omicron in hospital are becoming more common? | Wilson, MG; Bhuiya, AR; Bain, T; Al-Khateeb, S; Mansilla, C; Mehta, V; Sood, T; Soueidan, S; Rintjema, J; Waddell, K; Wang, A; Wang, Q; Wang, X; Lavis, JN |
| Jan-2022 | COVID-19 rapid evidence profile #28: What is the filtration performance of KN95 masks compared to surgical and N95 masks, and how can their use be optimized in hospital settings? | Al-Khateeb, S; Bain, T; Bhuiya, AR; Mansilla, C; Mehta, V; Sood, T; Wang, Q; Soueidan, S; Rintjema, J; Wang, A; Lavis, JN; Wilson, MG |
| Apr-2020 | COVID-19 rapid evidence profile #3: What is the evidence about international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #4: What are the most effective non-medical masks for preventing community transmission of COVID-19, and should they be required for all of society? | Wilson, MG; Gauvin, François-Pierre; Moat, KA; Waddell, K; Mansilla, C; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #5: What is known about the use of medical masks by essential non-medical workers to prevent community transmission of COVID-19? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #6: What is known about strategies for supporting the use of masks under shortage conditions to prevent COVID-19? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #7: What are the international lessons learned from re-opening non-COVID-19 activities in hospitals? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #8: How effective is temperature taking at borders or in general as a screening tool to identify people who may have COVID-19 and need to take appropriate action? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| Mar-2023 | Rapid evidence profile #32: What are the characteristics of living-evidence syntheses currently available about public-health issues? | Wilson, MG; Mansilla, C; Waddell, K; Neumann, S; Kostopoulos, A; Rogers, K; Dobbins, M; Lavis, JN |
| Nov-2019 | Rapid synthesis: Examining the effects of nurse practitioners on the quadruple aim | Wilson, MG; Mansilla, C; Filbey, L |
